Time-Restricted Eating May Improve MASLD Outcomes
A long-term observational study suggests that time-restricted eating (TRE) is more effective than other lifestyle interventions for managing metabolic dysfunction-associated steatotic liver disease (MASLD). Participants using TRE showed significant improvements in liver fat, fibrosis, and metabolic health.
Why it matters
Identifying effective, non-invasive management strategies for liver disease can significantly improve patient outcomes and reduce the burden on healthcare systems.
TIME-RESTRICTED eating could offer sustained benefits for people with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), according to new long-term research.
The prospective, real-world observational study found that time-restricted eating (TRE), a form of intermittent fasting, was associated with greater improvements in liver fat, fibrosis-related measures, and metabolic health than several other commonly used management strategies.
Researchers followed adults with MASLD or clinically suspected MASH who selected one of five management strategies through shared clinical decision-making. These included TRE for participants with MASLD or suspected MASH, Orlistat-supported lifestyle modification, a 1,500-kcal balanced diet, and exercise-focused lifestyle counselling.
Participants following TRE typically restricted their daily caloric intake to an approximately 8-hour eating window.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in